Evidence map›Paper›PMID 39699814›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Exosome Isolation from Pericardial Fluids.

Dhananjie N K Chandrasekera

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Dhananjie N K ChandrasekeraDepartment of Cardiac Physiology, National Cerebral and Cardiovascular Center, Osaka, Japan. dhananjiec@ncvc.go.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular vehicles such as exosomes which lie in the size range of 30-150 nm have gained significant attention due to their ability to contain molecular cargoes. These vesicles are released by various cells and are found to stably carry their molecular cargoes to recipient cells via different biological fluids. Therefore, exosomes isolated from various fluids such as plasma, urine, and pericardial fluid have been extensively studied in recent years. However, due to the miniscule nature of exosomes, isolation of exosomes from biological fluids has been a challenge, mainly due to low yields, contamination from large vesicles and proteins, and variable starting sample volumes. The following protocol describes the isolation of exosomes from human pericardial fluid samples collected from patients undergoing coronary artery bypass graft surgery. The exosomes isolated from these samples have been previously shown to have increased expression of cardiovascular molecular markers. Due to the precious nature of the patient samples, the exosomes isolated from this protocol have been validated to confirm their purity and viability for downstream applications.

Indexed as

ExosomesPericardial FluidBiomarkersCell FractionationCoronary Artery BypassHumansUltracentrifugationBiomarkersExosomesExtracellular vesiclesNanovesiclesPericardial fluidPrecipitationSize exclusion chromatography

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.